The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Aurinia Pharmaceuticals Inc(NASDAQ:AUPH) 
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes therapies to treat various diseases with unmet medical need in Japan and China. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agree...
Website: http://www.auriniapharma.com
Founded: 2012
Full Time Employees: 62
Sector: Healthcare
Industry: Biotechnology
Aurinia Pharmaceuticals Days Payable Outstanding ttm (DPO)
Aurinia Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Aurinia Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Aurinia Pharmaceuticals Op Cashflow Per Share ttm
Aurinia Pharmaceuticals Free Cashflow Per Share ttm
Aurinia Pharmaceuticals Cash Per Share ttm
Aurinia Pharmaceuticals P/S ratio ttm
Aurinia Pharmaceuticals (GAAP) P/E ratio ttm
Aurinia Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.